Cell therapy is at a pivotal moment, with global investment and innovation reshaping the landscape. While funding challenges persist, Europe and Asia are emerging as hotspots for rapid clinical development and strategic partnerships. The rise of in-vivo CAR-T and next-generation TCR approaches highlights a shift toward scalable, cost-effective therapies that could transform patient access and commercial feasibility.

Returning to London for its 9th year, the CAR-TCR Summit Europe is the essential forum to gain cutting-edge scientific insights, practical manufacturing strategies, and business intelligence to accelerate clinical success. Attendees will explore advances in novel CAR and TCR designs, armouring, and engineered signalling pathways, while also learning how leading institutions are improving scale, automation, and point-of-care solutions to reduce costs and enhance reliability.

Connect with Europe’s leading companies and research centres to stay ahead in innovation, strengthen manufacturing capabilities, and build the partnerships needed to drive the next generation of life-saving cell therapies across the continent and beyond.

View the event here.